Iron Deposition on SWI-Filtered Phase in the Subcortical Deep Gray Matter of Patients with Clinically Isolated Syndrome May Precede Structure-Specific Atrophy
暂无分享,去创建一个
M. Dwyer | R. Zivadinov | B. Weinstock-Guttman | J. Hagemeier | N. Bergsland | E. Carl | D. Hojnacki | C. Magnano | M. Dwyer | C. Kennedy | M. Heininen-Brown | B Weinstock-Guttman | N Bergsland | R Zivadinov | M G Dwyer | M Heininen-Brown | C Magnano | C Kennedy | E Carl | J Hagemeier | D Hojnacki | C. Kennedy | M.G. Dwyer | Cheryl L. Kennedy
[1] Yu-Chung N. Cheng,et al. Susceptibility weighted imaging (SWI) , 2004, Zeitschrift fur medizinische Physik.
[2] R. Grossman,et al. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging , 2009, Journal of magnetic resonance imaging : JMRI.
[3] Robert Zivadinov,et al. Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis A case-control study , 2012, NeuroImage.
[4] R. Henry,et al. Regional grey matter atrophy in clinically isolated syndromes at presentation , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[5] David H. Miller,et al. Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial , 2009, The Lancet Neurology.
[6] C. W. Tjoa,et al. MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis , 2005, Journal of the Neurological Sciences.
[7] Marco Bozzali,et al. Gray- and white-matter changes 1 year after first clinical episode of multiple sclerosis: MR imaging. , 2010, Radiology.
[8] M. Ramanathan,et al. Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor. , 2007, Human molecular genetics.
[9] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[10] Phil Lee,et al. Iron deposition is independent of cellular inflammation in a cerebral model of multiple sclerosis , 2011, BMC Neuroscience.
[11] J. Ranjeva,et al. Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis - a two-year longitudinal MRI/MRSI study of corpus callosum , 2007, Multiple sclerosis.
[12] David H. Miller,et al. Gray matter atrophy is related to long‐term disability in multiple sclerosis , 2008, Annals of neurology.
[13] H. Fenton,et al. LXXIII.—Oxidation of tartaric acid in presence of iron , 1894 .
[14] W Craelius,et al. Iron deposits surrounding multiple sclerosis plaques. , 1982, Archives of pathology & laboratory medicine.
[15] Rohit Bakshi,et al. Iron in chronic brain disorders: Imaging and neurotherapeutic implications , 2007, Neurotherapeutics.
[16] Robert Zivadinov,et al. Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis , 2011, Journal of Neurology.
[17] S Ropele,et al. Quantitative assessment of brain iron by R2* relaxometry in patients with clinically isolated syndrome and relapsing–remitting multiple sclerosis , 2009, Multiple sclerosis.
[18] David H. Miller,et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. , 2004, Brain : a journal of neurology.
[19] M Ramanathan,et al. Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis. , 2009, Brain : a journal of neurology.
[20] G A Johnson,et al. MRI of brain iron. , 1986, AJR. American journal of roentgenology.
[21] Rohit Bakshi,et al. Gray matter involvement in multiple sclerosis , 2007, Neurology.
[22] A. Thompson,et al. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis , 2005, The Lancet Neurology.
[23] Ferdinand Schweser,et al. Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: An approach to in vivo brain iron metabolism? , 2011, NeuroImage.
[24] S Ropele,et al. Determinants of brain iron in multiple sclerosis , 2011, Neurology.
[25] Rohit Bakshi,et al. Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis , 2010, Multiple sclerosis.
[26] Roland G. Henry,et al. Connecting white matter injury and thalamic atrophy in clinically isolated syndromes , 2009, Journal of the Neurological Sciences.
[27] R Marc Lebel,et al. Detecting lesions in multiple sclerosis at 4.7 tesla using phase susceptibility‐weighting and T2‐weighting , 2009, Journal of magnetic resonance imaging : JMRI.
[28] S. Nelson,et al. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron , 2008, Annals of neurology.
[29] Helen Nichol,et al. Brain iron detected by SWI high pass filtered phase calibrated with synchrotron X‐ray fluorescence , 2010, Journal of magnetic resonance imaging : JMRI.
[30] R. Rudick,et al. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS , 2001, Neurology.
[31] M. Filippi,et al. Deep grey matter T2 hypo-intensity in patients with paediatric multiple sclerosis , 2011, Multiple sclerosis.
[32] E. Haacke,et al. Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 1 , 2008, American Journal of Neuroradiology.
[33] R. Rudick,et al. Gray matter atrophy in multiple sclerosis: A longitudinal study , 2008, Annals of neurology.
[34] M. Calabrese,et al. The predictive value of gray matter atrophy in clinically isolated syndromes , 2011, Neurology.
[35] C. Guttmann,et al. Deep Gray Matter Involvement on Brain MRI Scans Is Associated with Clinical Progression in Multiple Sclerosis , 2009, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[36] Christian Langkammer,et al. Iron and Neurodegeneration in Multiple Sclerosis , 2011, Multiple sclerosis international.
[37] R. Bakshi,et al. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis , 2006, Multiple sclerosis.
[38] D. Ramasamy,et al. Extent of cerebellum, subcortical and cortical atrophy in patients with MS A case-control study , 2009, Journal of the Neurological Sciences.
[39] J A Helpern,et al. Quantitative Assessment of Iron Accumulation in the Deep Gray Matter of Multiple Sclerosis by Magnetic Field Correlation Imaging , 2007, American Journal of Neuroradiology.
[40] Rohit Bakshi,et al. Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. , 2005, Archives of neurology.
[41] R. Bakshi,et al. Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients , 2001, Journal of the Neurological Sciences.
[42] Jeffrey A. Cohen,et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.
[43] Chiara Romualdi,et al. Cortical atrophy is relevant in multiple sclerosis at clinical onset , 2007, Journal of Neurology.
[44] J. Ranjeva,et al. Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[45] R Bakshi,et al. MRI T2 shortening (‘black T2’) in multiple sclerosis: frequency, location, and clinical correlation , 2000, Neuroreport.
[46] J. Connor,et al. Iron, the substantia nigra and related neurological disorders. , 2009, Biochimica et biophysica acta.
[47] E M Haacke,et al. Iron stores and cerebral veins in MS studied by susceptibility weighted imaging. , 2010, International angiology : a journal of the International Union of Angiology.
[48] Steven M LeVine,et al. Iron deposits in multiple sclerosis and Alzheimer's disease brains , 1997, Brain Research.
[49] P. Matthews,et al. Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability , 2011, Multiple sclerosis.
[50] R. Zivadinov,et al. Iron deposition and inflammation in multiple sclerosis. Which one comes first? , 2011, BMC Neuroscience.
[51] M. Filippi,et al. T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis , 2009, Multiple sclerosis.
[52] Stephen M. Smith,et al. A Bayesian model of shape and appearance for subcortical brain segmentation , 2011, NeuroImage.
[53] R. Bakshi,et al. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. , 2002, Archives of neurology.